Notes on GLP-1 Care
Pricing trends, research updates and practical guidance on GLP-1 treatment, for patients and for the clinics that serve them.
Research
Is BPC-157 Legal in 2026? FDA Status, the HHS Draft Policy, and What the Evidence Shows
BPC-157 isn't FDA-approved. What changed in 2026: FDA's safety listing, the July advisory vote, and HHS's draft compounding policy, explained with sources.
Medications
Foundayo vs. Wegovy Pill: How the Two GLP-1 Weight-Loss Pills Compare (2026)
Foundayo and the Wegovy pill are the two FDA-approved GLP-1 weight-loss pills. Compare how to take them, trial results, side effects, and self-pay cost.
Pets
GLP-1 Drugs for Dogs and Cats: What's Approved, What's in Trials, and What Owners Should Know (2026)
No GLP-1 drug is approved for dogs or cats. Where pet GLP-1 trials stand in 2026, what Loyal's dog drugs are, and how to keep your GLP-1 away from pets.
Trends
The Next Weight-Loss Drugs: Where CagriSema, Retatrutide, Eloralintide and Amycretin Stand (November 2026)
Where the next weight-loss drugs stand: CagriSema's pending FDA decision, retatrutide's 2027 filing, and Phase 3 eloralintide and amycretin. None approved yet.
Lifestyle
How to Stop Muscle Loss on GLP-1 (Without Ruining Your Weight Loss)
Up to 40% of weight lost on GLP-1s can come from muscle. Here's the research-backed protein, training, and supplement protocol to keep the weight off and the lean mass on.
